Abstract:Abstract Long-lived species Homo sapiens have evolved robust protection mechanisms against cancer by repressing telomerase and maintaining short telomeres, thereby delaying the onset of the majority of cancer types until post-reproductive age. Indeed, telomerase is silent in most differentiated human cells, predominantly due to the transcriptional repression of its catalytic component telomerase reverse transcriptase (TERT) gene. The lack of telomerase/TERT expression leads to progressive telomere erosion in dividing human cells, whereas critically shortened telomere length induces a permanent growth arrest stage named replicative senescence. TERT/telomerase activation has been experimentally shown to be essential to cellular immortalization and malignant transformation by stabilizing telomere length and erasing the senescence barrier. Consistently, TERT expression/telomerase activity is detectable in up to 90% of human primary cancers. Compelling evidence has also accumulated that TERT contributes to cancer development and progression via multiple activities beyond its canonical telomere-lengthening function. Given these key roles of telomerase and TERT in oncogenesis, great efforts have been made to decipher mechanisms underlying telomerase activation and TERT induction. In the last two decades since the TERT gene and promoter were cloned, the derepression of the TERT gene has been shown to be achieved typically at a transcriptional level through dysregulation of oncogenic factors or signaling, post-transcriptional/translational regulation and genomic amplification. However, advances in high-throughput next-generation sequencing technologies have prompted a revolution in cancer genomics, which leads to the recent discovery that genomic alterations take center stage in activating the TERT gene. In this review article, we summarize critical mechanisms activating TERT transcription, with special emphases on the contribution of TERT promoter mutations and structural alterations at the TERT locus, and briefly discuss the underlying implications of these genomic events-driven TERT hyperactivity in cancer initiation/progression and potential clinical applications as well.

Irradiation‐induced Telomerase Activity and the Risk of Lung Cancer

Differential induction in telomerase activity among bladder cancer patients and controls on gamma-radiation.

Telomerase antagonist imetelstat increases radiation sensitivity in esophageal squamous cell carcinoma.

Telomerase Activity of Fibrobronchoscopic Brushing Cells in Non-Small Cell Lung Cancer

Variation of ATM Protein Expression in Response to Irradiation of Lymphocytes in Lung Cancer Patients and Controls.

Discriminating Association of a Common Telomerase Reverse Transcriptase Promoter Polymorphism with Telomere Parameters in Non-Small Cell Lung Cancer with or Without Epidermal Growth Factor Receptor Mutation.

Distinct Radiosensitivity of Lung Carcinoma Stem-Like Side Population and Main Population Cells.

Mns16a Tandem Repeats Minisatellite Of Human Telomerase Gene And Cancer Risk: A Meta-Analysis

Investigating the genetic instability in the peripheral lymphocytes of 36 untreated lung cancer patients with comet assay and micronucleus assay.

Cell Cycle Checkpoints, DNA Damage/repair, and Lung Cancer Risk.

Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players

Irradiation increases the immunogenicity of lung cancer cells and irradiation-based tumor cell vaccine elicits tumor-specific T cell responses in vivo.

Differential Gene Expression Profiles of DNA Repair Genes in Esophageal Cancer Cells after X-ray Irradiation

Telomerase mutations and carcinogenesis

Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study.

Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications

Telomere length in peripheral blood leukocytes and lung cancer risk: a large case-control study in Caucasians.

Telomere dysfunction: a potential cancer predisposition factor.

P-150 * RECURRENT TELOMERASE REVERSE TRANSCRIPTASE PROMOTER MUTATIONS IN NON-SMALL-CELL LUNG CANCERS

POT1 involved in telomeric DNA damage repair and genomic stability of cervical cancer cells in response to radiation

A Tandem Repeat of Human Telomerase Reverse Transcriptase (htert) and Non Small Cell Lung Cancer Development and Survival in Chinese Population